Sign In
Buy BIIB
$196.45
+0.490 (+0.250%)
At Close: Jun 04, 2026
European Commission grants marketing approval to Biogen's ALS drug
06:08pm, Thursday, 30'th May 2024
Biogen said on Thursday that the European Commission has granted marketing authorization under exceptional circumstances for its amyotrophic lateral sclerosis (ALS) drug Qalsody.
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of July 22, 2024 in Biogen Lawsuit - BIIB
05:35pm, Thursday, 30'th May 2024
NEW YORK, NY / ACCESSWIRE / May 30, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow th
NEW YORK , May 30, 2024 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Biogen Inc. ("Biogen" or the "Company") (NASDAQ: BIIB) and certain officers. The clas
Biogen Receives European Commission Approval for QALSODY® (tofersen), the First Therapy to Treat a Rare, Genetic Form of ALS
04:51pm, Thursday, 30'th May 2024
CAMBRIDGE, Mass., May 30, 2024 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced the European Commission (EC) has granted marketing authorization under exceptional circumstances and maintained
Class Action Filed Against Biogen Inc. (BIIB) Seeking Recovery for Investors – Contact Levi & Korsinsky
04:15pm, Thursday, 30'th May 2024
NEW YORK, NY / ACCESSWIRE / May 30, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow th
NEW YORK, NY / ACCESSWIRE / May 30, 2024 / Leading law firm Bleichmar Fonti & Auld LLP announces the upcoming July 22, 2024, deadline in the Biogen Inc. (Nasdaq:BIIB) Securities Class Action Lawsuit.
BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Biogen Inc. (“Biogen” or the “Company”)
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) Investors
12:07pm, Thursday, 30'th May 2024
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) Investors.
Biogen Inc. Securities Fraud Class Action Lawsuit Pending: Contact Levi & Korsinsky Before July 22, 2024 to Discuss Your Rights - BIIB
11:30am, Thursday, 30'th May 2024
NEW YORK, NY / ACCESSWIRE / May 30, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow th
NEW YORK--(BUSINESS WIRE)---- $BIIB #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been fi
Biogen Inc. Investor Notice: Robbins LLP Reminds Stockholders of the Class Action Against BIIB
08:35pm, Tuesday, 28'th May 2024
SAN DIEGO--(BUSINESS WIRE)---- $BIIB #BIIB--Robbins LLP is Investigating Allegations that Biogen Inc. (BIIB) Misled Investors Regarding its Financial Prospects.
Why Is Biogen (BIIB) Up 7.7% Since Last Earnings Report?
12:39pm, Friday, 24'th May 2024
Biogen (BIIB) reported earnings 30 days ago. What's next for the stock?
NEW YORK , May 23, 2024 /PRNewswire/ -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed agai
Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Biogen Inc. (BIIB) Investors
07:32pm, Thursday, 23'rd May 2024
NEW YORK--(BUSINESS WIRE)---- $BIIB #Investigation--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed in the U.S. District Court for the District of Colorado on
NEW YORK--(BUSINESS WIRE)---- $BIIB #classaction--Attorney Advertising--Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been fi
